Medtronic plc (2M6.F)
| Previous close | 75.69 |
| Open | 76.70 |
| Bid | 0.00 x 100000 |
| Ask | 0.00 x 100000 |
| Day's range | 76.66 - 76.70 |
| 52-week range | 65.30 - 83.34 |
| Volume | |
| Avg. volume | 905 |
| Market cap | 103.623B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 26.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.57 (3.40%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- GlobeNewswire
Medtronic Recognized for Health Monitoring Innovation in 8th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been selected as winner of the “Best New Mo
- PR Newswire
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.
- PR Newswire
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
